>
Switch to:

Cullinan Oncology Current Ratio

: 39.67 (As of Dec. 2019)
View and export this data going back to 2021. Start your Free Trial

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Cullinan Oncology's current ratio for the quarter that ended in Dec. 2019 was 39.67.

Cullinan Oncology has a current ratio of 39.67. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.

The historical rank and industry rank for Cullinan Oncology's Current Ratio or its related term are showing as below:


Cullinan Oncology Current Ratio Historical Data

The historical data trend for Cullinan Oncology's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cullinan Oncology Annual Data
Trend Dec18 Dec19 Dec20
Current Ratio
25.85 39.67 14.82

Cullinan Oncology Semi-Annual Data
Dec18 Dec19 Dec20
Current Ratio 25.85 39.67 14.82

Competitive Comparison

For the Biotechnology subindustry, Cullinan Oncology's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Cullinan Oncology Current Ratio Distribution

For the Biotechnology industry and Healthcare sector, Cullinan Oncology's Current Ratio distribution charts can be found below:

* The bar in red indicates where Cullinan Oncology's Current Ratio falls into.



Cullinan Oncology Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Cullinan Oncology's Current Ratio for the fiscal year that ended in Dec. 2019

Current Ratio (A: Dec. 2019 )=Total Current Assets (A: Dec. 2019 )/Total Current Liabilities (A: Dec. 2019 )
=100.091/2.523
=39.67

Cullinan Oncology's Current Ratio for the quarter that ended in Dec. 2019 is calculated as

Current Ratio (Q: Dec. 2019 )=Total Current Assets (Q: Dec. 2019 )/Total Current Liabilities (Q: Dec. 2019 )
=100.091/2.523
=39.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cullinan Oncology  (NAS:CGEM) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Cullinan Oncology Current Ratio Related Terms

Thank you for viewing the detailed overview of Cullinan Oncology's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cullinan Oncology Business Description

Cullinan Oncology logo
Industry
Healthcare » Biotechnology NAICS : 541713 SIC : 2834
Comparable Companies
Traded in Other Exchanges
N/A
Address
One Main Street, Suite 520, Cambridge, MA, USA, 02142
Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.

Cullinan Oncology Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)